When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PVCT - Provectus Biopharma expands RBD research collaboration for cancer treatment
Provectus Biopharmaceuticals Inc
Provectus (OTC:PVCT-1.9%) has expanded its sponsored research collaboration with the University of Calgary, under which the research team will now investigate oral dosing of Provectus's rose bengal disodium (RBD) in in vivo murine models for refractory adult solid tumors that are high-risk phenotypes and have high metastatic potential.
More news on: Provectus Biopharmaceuticals, Inc., Healthcare stocks news,